Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.
Superoxide dismutase reduces the inflammatory response to Aspergillus and Alternaria in human sinonasal epithelial cells derived from patients with chronic rhinosinusitis.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst. 1997 Dec 03; 89(23):1789-96.
View in:
PubMed
subject areas
Adult
Aged
Antimetabolites, Antineoplastic
Antineoplastic Agents, Alkylating
Antineoplastic Combined Chemotherapy Protocols
Buthionine Sulfoximine
Drug Administration Schedule
Female
Glutathione
Humans
Infusions, Intravenous
Lymphocytes
Male
Melphalan
Middle Aged
Neoplasms
Treatment Outcome
authors with profiles
David M. Mahvi